{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:41:25Z","timestamp":1778773285993,"version":"3.51.4"},"reference-count":38,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.3201\/eid2606.191141","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T14:33:21Z","timestamp":1588343601000},"page":"1174-1181","source":"Crossref","is-referenced-by-count":35,"title":["Invasive Group B <i>Streptococcus<\/i> Infections in Adults, England, 2015\u20132016"],"prefix":"10.3201","volume":"26","author":[{"given":"Simon M.","family":"Collin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandini","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Lamagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2606.191141-202005180957-R1","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s10096-017-2983-y","article-title":"Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004-2014.","volume":"36","author":"Kern\u00e9is","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.3201\/eid2606.191141-202005180957-R2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1471-2334-11-149","article-title":"Streptococcus agalactiae in adults at Chiang Mai University Hospital: a retrospective study.","volume":"11","author":"Chaiwarith","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2606.191141-202005180957-R3","first-page":"CR447","article-title":"Streptococcus agalactiae infections in non-pregnant adults: single center experience of a growing clinical problem.","volume":"12","author":"Falagas","year":"2006","journal-title":"Med Sci Monit"},{"key":"key-10.3201\/eid2606.191141-202005180957-R4","doi-asserted-by":"crossref","first-page":"379.e9","DOI":"10.1016\/j.cmi.2015.11.020","article-title":"Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975\u20132014.","volume":"22","author":"Bjornsdottir","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2606.191141-202005180957-R5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1086\/599369","article-title":"Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007.","volume":"49","author":"Skoff","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2606.191141-202005180957-R6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jamainternmed.2018.7269","article-title":"Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008\u20132016.","volume":"179","author":"Francois Watkins","year":"2019","journal-title":"JAMA Intern Med"},{"key":"key-10.3201\/eid2606.191141-202005180957-R7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/cid\/cit337","article-title":"Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010.","volume":"57","author":"Lamagni","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2606.191141-202005180957-R8","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3109\/23744235.2015.1131330","article-title":"The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment.","volume":"48","author":"Ballard","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"key-10.3201\/eid2606.191141-202005180957-R9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijid.2015.04.006","article-title":"Invasive group B streptococcal disease in non-pregnant adults, R\u00e9union Island, 2011.","volume":"35","author":"Camuset","year":"2015","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2606.191141-202005180957-R10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.medmal.2007.04.003","article-title":"[Invasive Streptococcus agalactiae infections in non-pregnant adults]","volume":"37","author":"Lefebvre","year":"2007","journal-title":"Med Mal Infect"},{"key":"key-10.3201\/eid2606.191141-202005180957-R11","first-page":"237","article-title":"Group B streptococcal bacteremia in non-pregnant adults.","volume":"39","author":"Huang","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"key-10.3201\/eid2606.191141-202005180957-R12","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1016\/j.vaccine.2017.09.087","article-title":"Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics.","volume":"37","author":"Vekemans","year":"2019","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2606.191141-202005180957-R13","doi-asserted-by":"publisher","first-page":"D7","DOI":"10.1016\/j.vaccine.2013.01.009","article-title":"An overview of global GBS epidemiology.","volume":"31","author":"Le Doare","year":"2013","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2606.191141-202005180957-R14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jinf.2013.07.021","article-title":"Evaluation of a national microbiological surveillance system to inform automated outbreak detection.","volume":"67","author":"Freeman","year":"2013","journal-title":"J Infect"},{"key":"key-10.3201\/eid2606.191141-202005180957-R15","unstructured":"PHE Second Generation Surveillance System (SGSS). Laboratory reporting to Public Health England: a guide for diagnostic laboratories. London: Public Health England; 2016."},{"key":"key-10.3201\/eid2606.191141-202005180957-R16","unstructured":"Public Health England. Laboratory surveillance of pyogenic and non-pyogenic streptococcal bacteraemia in England, Wales and Northern Ireland: 2016. London: Public Health England; 2017."},{"key":"key-10.3201\/eid2606.191141-202005180957-R17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/ije\/dyx015","article-title":"Data Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC).","volume":"46","author":"Herbert","year":"2017","journal-title":"Int J Epidemiol"},{"key":"key-10.3201\/eid2606.191141-202005180957-R18","unstructured":"NHS Digital. Demographics Batch Service Bureau (DBSB): NHS number batch tracing. London: Health and Social Care Information Centre; 2017."},{"key":"key-10.3201\/eid2606.191141-202005180957-R19","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1093\/cid\/cix660","article-title":"Maternal disease with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses.","volume":"65","author":"Hall","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2606.191141-202005180957-R20","unstructured":"NHS Digital. Quality and Outcomes Framework (QOF) 2015\u201316. 2016 [cited January 2019]. http:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data\/quality-and-outcomes-framework-qof-2015\u201316."},{"key":"key-10.3201\/eid2606.191141-202005180957-R21","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1001\/jama.1991.03470080082034","article-title":"Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta.","volume":"266","author":"Schwartz","year":"1991","journal-title":"JAMA"},{"key":"key-10.3201\/eid2606.191141-202005180957-R22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJM199306243282503","article-title":"A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults.","volume":"328","author":"Farley","year":"1993","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2606.191141-202005180957-R23","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1016\/j.vaccine.2018.09.058","article-title":"Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.","volume":"36","author":"Giorgakoudi","year":"2018","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2606.191141-202005180957-R24","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.1016\/j.vaccine.2017.08.085","article-title":"Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.","volume":"35","author":"Kim","year":"2017","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2606.191141-202005180957-R25","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.1016\/j.vaccine.2018.10.001","article-title":"An economic case for a vaccine to prevent group A streptococcus skin infections.","volume":"36","author":"Cannon","year":"2018","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2606.191141-202005180957-R26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ijid.2019.04.017","article-title":"Group B Streptococcus in surgical site and non-invasive bacterial infections worldwide: A systematic review and meta-analysis.","volume":"83","author":"Collin","year":"2019","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2606.191141-202005180957-R27","doi-asserted-by":"publisher","first-page":"12911","DOI":"10.1073\/pnas.1717161115","article-title":"Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR.","volume":"115","author":"Sevilla","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2606.191141-202005180957-R28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/jac\/dky542","article-title":"Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in Japan.","volume":"74","author":"Kitamura","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2606.191141-202005180957-R29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jinf.2019.11.008","article-title":"Hospital clusters of invasive Group B Streptococcal disease: A systematic review.","volume":"79","author":"Collin","year":"2019","journal-title":"J Infect"},{"key":"key-10.3201\/eid2606.191141-202005180957-R30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1017\/S0950268814000533","article-title":"Inequalities in the incidence of infectious disease in the North East of England: a population-based study.","volume":"143","author":"Hughes","year":"2015","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid2606.191141-202005180957-R31","doi-asserted-by":"publisher","first-page":"e75131","DOI":"10.1371\/journal.pone.0075131","article-title":"Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study.","volume":"8","author":"Millett","year":"2013","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2606.191141-202005180957-R32","doi-asserted-by":"publisher","first-page":"e012323","DOI":"10.1136\/bmjopen-2016-012323","article-title":"Maternal morbidity and mortality from severe sepsis: a national cohort study.","volume":"6","author":"Acosta","year":"2016","journal-title":"BMJ Open"},{"key":"key-10.3201\/eid2606.191141-202005180957-R33","doi-asserted-by":"publisher","first-page":"e010790","DOI":"10.1136\/bmjopen-2015-010790","article-title":"Factors influencing women\u2019s attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey.","volume":"6","author":"McQuaid","year":"2016","journal-title":"BMJ Open"},{"key":"key-10.3201\/eid2606.191141-202005180957-R34","unstructured":"Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR). London: Public Health England; 2018."},{"key":"key-10.3201\/eid2606.191141-202005180957-R35","unstructured":"Public Health England. Laboratory surveillance of Staphylococcus aureus bacteraemia in England, Wales and Northern Ireland: 2017. London: Public Health England; 2018."},{"key":"key-10.3201\/eid2606.191141-202005180957-R36","unstructured":"Public Health England. Laboratory surveillance of Escherichia coli bacteraemia in England, Wales and Northern Ireland: 2017. London: Public Health England; 2018."},{"key":"key-10.3201\/eid2606.191141-202005180957-R37","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1086\/432804","article-title":"Group B streptococcal infections in elderly adults.","volume":"41","author":"Edwards","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2606.191141-202005180957-R38","unstructured":"UK Standards for Microbiology Investigations. Investigation of bronchoalveolar lavage, sputum and associated specimens. London: Public Health England; 2019."}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/26\/6\/19-1141_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:33:55Z","timestamp":1732988035000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/26\/6\/19-1141_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2606.191141","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}